214557-91-2

Upstream product

• 214557-89-8 3,5,7-trifluoroadamantane-1-carboxylic acid 
• 100-51-6 benzyl alcohol 
• 73600-37-0 3,5-difluoroadamantane-1-carboxylic acid 
• 214557-86-5 methyl 3,5-difluoro-7-hydroxyadamantane-1-carboxylate 
• 214557-84-3 methyl 3,5,7-trifluoroadamantane-1-carboxylate 

Relevant academic research and scientific papers

Preparation of fluoroadamantane acids and amines: Impact of bridgehead fluorine substitution on the solution- and solid-state properties of functionalized adamantanes

Functionalized adamantanes are utilized as medicinal therapeutics and a practical route to novel bridgehead fluorinated adamantylamines and acids including fully fluorinated 3,5,7-tri-fluoroadamantane-1-carboxylic acid 1 and 3,5,7-trifluoroadamantane-1-am

SUBSTITUTED TRIAZINONES AS THYROID HORMONE RECEPTOR AGONISTS

The application relates to a compound of Formula (I') or (I), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of thyroid hormone receptors, a pharmaceutical composition comprising a compound of Formula (I') or (I), and a method of treating or preventing a disease or disorder regulated by thyroid hormone.